Pharmacokinetic study of transdermal fentanyl among of two types of one-day patches.

Pharmacokinetic study of transdermal fentanyl among of two types of one-day patches. - Pharmacokinetic study of transdermal fentanyl among of two types of one-day patches.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007149

Enrollment

Registered

2012-01-26

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Blood concentration is measured after randomizing patients to Fentos Tape or OneDuro Patch. Blood concentration is measured after randomizing patients to OneDuro Patch or Fentos Tape.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient who treated with transdermal fentanyl of one-day patches. 2. Patient who are capable of providing written informed consent.

Exclusion criteria

Exclusion criteria: Patients seems inadequate for this study by investigators

Design outcomes

Primary

Measure	Time frame
Blood concentration of fentanyl	—

Countries

Japan

Contacts

Public ContactKyohei Watanabe

University of Fukui hospital Department of Pharmacy

kyohei@u-fukui.ac.jp0776-61-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026